{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:54:56Z","timestamp":1793296496725,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.euo.2025.05.007","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T17:12:02Z","timestamp":1748452322000},"page":"1533-1543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Global Trends in the Incidence, Mortality, and Risk-attributable Deaths for Prostate, Bladder, and Kidney Cancers: A Systematic Analysis from the Global Burden of Disease Study 2021"],"prefix":"10.1016","volume":"8","author":[{"given":"David Ka-Wai","family":"Leung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris Ho-Ming","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Ching-Ho","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian Wai-Hei","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Qin-Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry Yue-Hong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffi Kar-Kei","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sikun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Fai","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy Y.C.","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.05.007_b0005","unstructured":"Global Burden of Disease Cancer Collaborators, Fitzmaurice C, Abate D, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study. JAMA Oncol 2019;5:1749\u201368."},{"key":"10.1016\/j.euo.2025.05.007_b0010","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/iju.13376","article-title":"Epidemiology of urothelial carcinoma","volume":"24","author":"Miyazaki","year":"2017","journal-title":"Int J Urol"},{"key":"10.1016\/j.euo.2025.05.007_b0015","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/ndt\/gfae036","article-title":"Global epidemiology of kidney cancer","volume":"39","author":"Cirillo","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.euo.2025.05.007_b0020","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 Update on prostate cancer epidemiology and risk factors\u2014a systematic review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.05.007_b0025","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euo.2025.05.007_b0030","first-page":"805","article-title":"Epidemiology of prostate cancer: current status","volume":"19","author":"Tao","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.euo.2025.05.007_b0035","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euo.2025.05.007_b0040","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euo.2025.05.007_b0045","unstructured":"Global Burden of Disease Cancer Collaborators, Kocarnik JM, Compton K, et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. JAMA Oncol 2022;8:420\u201344."},{"key":"10.1016\/j.euo.2025.05.007_b0050","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s11357-021-00494-z","article-title":"Associations between sociodemographic factors, health spending, disease burden, and life expectancy of older adults (70 + years old) in 22 countries in the Western Pacific Region, 1995\u20132019: estimates from the Global Burden of Disease (GBD) Study 2019","volume":"44","author":"Molassiotis","year":"2022","journal-title":"Geroscience"},{"key":"10.1016\/j.euo.2025.05.007_b0055","doi-asserted-by":"crossref","unstructured":"GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 2024;403:2162\u2013203.","DOI":"10.1016\/S0140-6736(24)00933-4"},{"key":"10.1016\/j.euo.2025.05.007_b0060","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1186\/s12889-024-19923-7","article-title":"Global, regional, and national burden of intracerebral hemorrhage and its attributable risk factors from 1990 to 2021: results from the 2021 Global Burden of Disease Study","volume":"24","author":"Xu","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.euo.2025.05.007_b0065","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1016\/j.clgc.2023.02.003","article-title":"Global trends of prostate cancer by age, and their associations with gross domestic product (GDP), human development index (HDI), smoking, and alcohol drinking","volume":"21","author":"Huang","year":"2023","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euo.2025.05.007_b0070","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.euf.2020.12.020","article-title":"A global trend analysis of kidney cancer incidence and mortality and their associations with smoking, alcohol consumption, and metabolic syndrome","volume":"8","author":"Huang","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2025.05.007_b0075","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.eururo.2020.09.006","article-title":"Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita","volume":"78","author":"Teoh","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.05.007_b0080","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3390\/ijerph14101147","article-title":"Clinical effects of cigarette smoking: epidemiologic impact and review of pharmacotherapy options","volume":"14","author":"Onor","year":"2017","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.euo.2025.05.007_b0085","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1253\/circj.CJ-14-0850","article-title":"Global trend in overweight and obesity and its association with cardiovascular disease incidence","volume":"78","author":"Yatsuya","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.euo.2025.05.007_b0090","doi-asserted-by":"crossref","first-page":"604","DOI":"10.46234\/ccdcw2021.160","article-title":"Major trends in population growth around the world","volume":"3","author":"Gu","year":"2021","journal-title":"China CDC Wkly"},{"key":"10.1016\/j.euo.2025.05.007_b0095","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(16)32381-9","article-title":"Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble","volume":"389","author":"Kontis","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2025.05.007_b0100","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/agm2.12347","article-title":"The increasing prevalence of cancer in the elderly: an investigation of epidemiological trends","volume":"7","author":"Prathap","year":"2024","journal-title":"Aging Med (Milton)"},{"key":"10.1016\/j.euo.2025.05.007_b0105","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(14)61461-6","article-title":"Towards a comprehensive public health response to population ageing","volume":"385","author":"Beard","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2025.05.007_b0110","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s43018-024-00880-4","article-title":"The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis","volume":"6","author":"Shah","year":"2025","journal-title":"Nat Cancer"},{"key":"10.1016\/j.euo.2025.05.007_b0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.eururo.2020.04.063","article-title":"Risks from deferring treatment for genitourinary cancers: a collaborative review to aid triage and management during the COVID-19 pandemic","volume":"78","author":"Wallis","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.05.007_b0120","first-page":"51","article-title":"The real-world lifetime economic burden of urothelial carcinoma by stage at diagnosis","volume":"6","author":"Aly","year":"2020","journal-title":"J Clin Pathw"},{"key":"10.1016\/j.euo.2025.05.007_b0125","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41391-022-00628-0","article-title":"Trends in prostate cancer mortality in the United States of America, by state and race, from 1999 to 2019: estimates from the centers for disease control WONDER database","volume":"26","author":"Jani","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euo.2025.05.007_b0130","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1186\/s12885-023-11272-9","article-title":"Addressing cancer care in low- to middle-income countries: a call for sustainable innovations and impactful research","volume":"23","author":"Stefan","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.euo.2025.05.007_b0135","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/carcin\/bgp263","article-title":"The global burden of cancer: priorities for prevention","volume":"31","author":"Thun","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.euo.2025.05.007_b0140","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3332\/ecancer.2022.1449","article-title":"Cancer-related costs, the resulting financial impact and coping strategies among cancer survivors living in a setting with a pluralistic health system: a qualitative study","volume":"16","author":"Fnu","year":"2022","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.euo.2025.05.007_b0145","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.eururo.2024.12.002","article-title":"The financial burden of localized and metastatic bladder cancer","volume":"87","author":"Scilipoti","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.05.007_b0150","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.eururo.2022.08.001","article-title":"A plea for economically sustainable evidence-based guidelines","volume":"82","author":"Martini","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.05.007_b0155","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.euf.2023.12.002","article-title":"The financial burden of guideline-recommended cancer medications for metastatic urothelial carcinoma","volume":"10","author":"Contieri","year":"2024","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2025.05.007_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221775","article-title":"Global incidence of prostate cancer in developing and developed countries with changing age structures","volume":"14","author":"Teoh","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.euo.2025.05.007_b0165","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.eururo.2014.12.006","article-title":"Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Goteborg randomized population-based prostate cancer screening trial","volume":"68","author":"Arnsrud Godtman","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.05.007_b0170","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00345-024-04949-8","article-title":"Global burden of bladder cancer mortality in 2020 and 2040 according to GLOBOCAN estimates","volume":"42","author":"Weber","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2025.05.007_b0175","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1007\/s00432-022-04464-6","article-title":"The impact of smoking on recurrence and progression of non-muscle invasive bladder cancer: a systematic review and meta-analysis","volume":"149","author":"Slusarczyk","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.euo.2025.05.007_b0180","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2013.06.010","article-title":"Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature","volume":"65","author":"Crivelli","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.05.007_b0185","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ijc.34560","article-title":"Bladder cancer risk in relation to occupations held in a nationwide case-control study in Iran","volume":"153","author":"Hosseini","year":"2023","journal-title":"Int J Cancer"},{"key":"10.1016\/j.euo.2025.05.007_b0190","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1200\/JCO.22.02472","article-title":"Smoking cessation after diagnosis of kidney cancer is associated with reduced risk of mortality and cancer progression: a prospective cohort study","volume":"41","author":"Sheikh","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2025.05.007_b0195","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of renal cell carcinoma","volume":"75","author":"Capitanio","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.05.007_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.928619","article-title":"Association between metabolic syndrome and risk of renal cell cancer: a meta-analysis","volume":"12","author":"Du","year":"2022","journal-title":"Front Oncol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125001336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125001336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T08:39:46Z","timestamp":1778143186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125001336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2588931125001336"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.05.007","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global Trends in the Incidence, Mortality, and Risk-attributable Deaths for Prostate, Bladder, and Kidney Cancers: A Systematic Analysis from the Global Burden of Disease Study 2021","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}